Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain.

Autor: Sidorova MV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Bibilashvili RS; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Avdeev DV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Kozhokar US; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Palkeeva ME; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Ovchinnikov MV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Molokoedov AS; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Shirokov DA; Federal Research and Clinical Center of Physical Chemical Medicine, Federal Medical Biological Agency, Moscow, Russia.; Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Moscow, Russia., Semyonova AV; Federal Research and Clinical Center of Physical Chemical Medicine, Federal Medical Biological Agency, Moscow, Russia., Uvarova VI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia., Kulyaev PO; Sirius University of Science and Technology, Sochi, Russia., Khvatov EV; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia., Ignatova AA; Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Feofanov AV; Lomonosov Moscow State University, Moscow, Russia., Osolodkin DI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Porozov YB; Sirius University of Science and Technology, Sochi, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Kozlovskaya LI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia. kozlovskaya_li@chumakovs.su.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. kozlovskaya_li@chumakovs.su., Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Parfyonova YV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Egorov AM; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2022 Dec; Vol. 507 (1), pp. 237-241. Date of Electronic Publication: 2022 Dec 29.

New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents.

Autor: Neganova ME; Institute of Physiologically Active Compounds of Russian Academy of Sciences, Severny pr, 1. Chernogolovka, Moscow Region, 142432, Russian Federation., Klochkov SG; Institute of Physiologically Active Compounds of Russian Academy of Sciences, Severny pr, 1. Chernogolovka, Moscow Region, 142432, Russian Federation., Aleksandrova YR; Institute of Physiologically Active Compounds of Russian Academy of Sciences, Severny pr, 1. Chernogolovka, Moscow Region, 142432, Russian Federation., Osipov VN; N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Kashirskoe sh., 23, Moscow, 115478, Russian Federation., Avdeev DV; National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, Street 3-ja Cherepkovskaja 15A, Moscow, 121552, Russian Federation., Pukhov SA; Institute of Physiologically Active Compounds of Russian Academy of Sciences, Severny pr, 1. Chernogolovka, Moscow Region, 142432, Russian Federation., Gromyko AV; JSC Pharm-Sintez, Vereyskaya Str., 29, bld. 134, Moscow, 121357, Russian Federation., Aliev G; Institute of Physiologically Active Compounds of Russian Academy of Sciences, Severny pr, 1. Chernogolovka, Moscow Region, 142432, Russian Federation.

Publikováno v: Anti-cancer agents in medicinal chemistry [Anticancer Agents Med Chem] 2021; Vol. 21 (5), pp. 597-610.